Patents by Inventor Fubing WANG

Fubing WANG has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12517057
    Abstract: A spectroscopy and artificial intelligence-interaction serum analysis method includes: collecting bulk SERS spectral data of clinical serum samples, performing dimension reduction on the spectral data by using a covariance matrix to obtain spectral different peak positions of cancer patients and normal individuals, and performing spectral data processing and algorithm identification by using an svm model of an artificial intelligence algorithm to obtain a cancer identification rate. Compared with the conventional serum analysis method, the spectroscopy and artificial intelligence-interaction serum analysis method requires no antibody-antigen or other biological specificity modification processes, and the serum of cancer patients and normal individuals can be identified more cheaply, rapidly and accurately.
    Type: Grant
    Filed: March 6, 2024
    Date of Patent: January 6, 2026
    Assignee: WUHAN UNIVERSITY
    Inventors: Xiangheng Xiao, Shilian Dong, Fubing Wang, Changzhong Jiang
  • Patent number: 12469607
    Abstract: The disclosure belongs to the field of genetic testing and biomedicine, relating to a method for constructing a prognostic model of hepatoma and an application thereof, comprising 1) obtaining and identifying fibroblasts with high FAP expression; 2) obtaining and identifying TAMs; 3) analyzing co-localization between fibroblasts with high FAP expression obtained and the TAMs obtained previously; 4) communicating and analyzing the fibroblasts with high FAP expression after the localization in the Step 3) with TAMs to obtain CCC ligand-receptor genes; 5) screening the CCC ligand-receptor genes obtained previously based on machine learning to obtain key CCC ligand-receptor genes; and 6) constructing a prognostic model of hepatoma according to the key CCC ligand-receptor genes obtained in the Step 5). The present disclosure provides a method for constructing a prognostic model of hepatoma that can be applied to auxiliary judgment of the prognosis of hepatoma patients and an application thereof.
    Type: Grant
    Filed: January 23, 2025
    Date of Patent: November 11, 2025
    Assignee: WUHAN UNIVERSITY
    Inventors: Fubing Wang, Fei Long, Wei Zhong
  • Publication number: 20250299833
    Abstract: The disclosure belongs to the field of genetic testing and biomedicine, relating to a method for constructing a prognostic model of hepatoma and an application thereof, comprising 1) obtaining and identifying fibroblasts with high FAP expression; 2) obtaining and identifying TAMs; 3) analyzing co-localization between fibroblasts with high FAP expression obtained and the TAMs obtained previously; 4) communicating and analyzing the fibroblasts with high FAP expression after the localization in the Step 3) with TAMs to obtain CCC ligand-receptor genes; 5) screening the CCC ligand-receptor genes obtained previously based on machine learning to obtain key CCC ligand-receptor genes; and 6) constructing a prognostic model of hepatoma according to the key CCC ligand-receptor genes obtained in the Step 5). The present disclosure provides a method for constructing a prognostic model of hepatoma that can be applied to auxiliary judgment of the prognosis of hepatoma patients and an application thereof.
    Type: Application
    Filed: January 23, 2025
    Publication date: September 25, 2025
    Applicant: WUHAN UNIVERSITY
    Inventors: Fubing WANG, Fei LONG, Wei ZHONG
  • Publication number: 20240210324
    Abstract: A spectroscopy and artificial intelligence-interaction serum analysis method includes: collecting bulk SERS spectral data of clinical serum samples, performing dimension reduction on the spectral data by using a covariance matrix to obtain spectral different peak positions of cancer patients and normal individuals, and performing spectral data processing and algorithm identification by using an svm model of an artificial intelligence algorithm to obtain a cancer identification rate. Compared with the conventional serum analysis method, the spectroscopy and artificial intelligence-interaction serum analysis method requires no antibody-antigen or other biological specificity modification processes, and the serum of cancer patients and normal individuals can be identified more cheaply, rapidly and accurately.
    Type: Application
    Filed: March 6, 2024
    Publication date: June 27, 2024
    Applicant: WUHAN UNIVERSITY
    Inventors: Xiangheng XIAO, Shilian DONG, Fubing WANG, Changzhong JIANG